GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business update

30 Apr 2007 07:49

ViaLogy PLC30 April 2007 Date: 30 April 2007On behalf of: ViaLogy plc ("ViaLogy" or "the Company") For immediate release ViaLogy PLC Business Update Vialogy SPMTM selected by US Department of Defence for joint experiments todevelop Joint Forces Protection and Base Security Systems London, April 30, 2007 -- ViaLogy PLC (LSE: VIY), announces that its Americansubsidiary, ViaLogy LLC, has been chosen by the US Department of Defence (DoD)to participate in joint experiments to support next-generation Joint ForceProtection Advanced Security (JFPASS) Joint Capabilities TechnologyDemonstration (JCTD). ViaLogy was selected to provide a Command and Controlplatform for the experiments. Recent DoD studies have found that current technologies, as employed, do notprovide a comprehensive, integrated and sustainable Joint Force Protectioncapability. The goal of JFPASS is to address these shortcomings with a potential$60 million combined services project to begin in 2008. The JFPASS JCTD is a joint services (Army, Navy, Air Force and Marines)initiative for integrating tactical systems, sensors and security personnel toprotect forces and over 600 facilities in the US and overseas. NATO and othercoalition partners have similar needs for base and force protection globally. ViaLogy will be providing its SPMTM (Sensor Policy Manager) product for theinternet protocol-enabled sensors and systems to accurately and immediatelyinterpret and disseminate information to pre-selected destinations. The lack ofsuch an effective interoperability between systems has previously been asignificant problem for both the military and public sectors. At a recent integration assessment supporting JFPASS JCTD in the Space and NavalWarfare Systems Centre (SPAWAR), San Diego, CA, ViaLogy successfullydemonstrated interoperability between two disparate operators, NorthropGrumman's Tactical Asset Security System (TASS) and the Joint BattlespaceCommand and Control Station (JBC2S) for unmanned systems. ViaLogy has alsointegrated a Lightweight Chemical Detector (LCD) from Smiths Detection tovalidate the IP-based plug-and-play capabilities of SPMTM. The LCD is part ofthe soldiers' hand-held equipment and is used for checking cargo, personnel orbuildings for chemical warfare agents. ViaLogy's SPMTM product provides a sensor-based policy engine for the rapiddetection, analysis and transmission of information. It exploits internetprotocol and patented signal processing to deliver interoperability to sensor,video and network sub-systems. Of major importance to potential users of SPMTM are its reliability,adaptability and affordability. "The product is designed for scaleableimplementation involving hundreds and even thousands of sensors," said Dr.Sandeep Gulati, ViaLogy's Chief Technology Officer. "JFPASS requirements presentan ideal opportunity for SPMTM. The technology thrives on the unexpected and, inthe event of a major incident, plays a vital role in detection and effectivedamage control." Previously, as NASA's Jet Propulsion Laboratory PrincipalScientist for sensor fusion, Dr. Gulati was extensively involved with sensorintensive command and control systems. ViaLogy CEO, Mr. Shah Talukder stated: "Higher demand for commercialoff-the-shelf products will shift procurement from project-centric toproduct-centric acquisition of technology. This will drive down project costsand timelines as it does in private sector procurement." Mr. Talukder who, prior to joining ViaLogy, developed the vision, strategy androad map for Cisco's Interoperability and Collaboration System (IPICS), added: "By delivering comprehensive sensor, video and tactical interoperability in anetwork-centric platform we believe SPM product will be able to meet JFPASS JCTDrequirements and play an integral part in the joint forces security project." For further information please contact: ViaLogy Shah Talukder, CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce Limited (NOMAD)Mark Percy +44 (0)20 7107 8000 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.